Background: Diagnosis of peritoneal carcinomatosis (PC) may be missed by preoperative imaging. We are presenting our experience with incidentally detected PC of colorectal origin treated with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) at the same operation
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologi...
Peritoneal Carcinomatosis (PC) is a late stage manifestation of several gastrointestinal malignancie...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. Th...
Background: Diagnosis of peritoneal carcinomatosis (PC) may be missed by preoperative imaging. We ar...
A subset of patients with colorectal cancer (CRC) develops synchronous or metachronous isolated peri...
Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surger...
Approximately 5% of colorectal cancer (CRC) patients will develop peritoneal carcinomatosis (PC) in ...
Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic...
The present study evaluates the accuracy of computed tomographic (CT) scan and positron emission tom...
OBJECTIVE: To review the literature with regard to the incidence and prognostic significance of peri...
Peritoneal carcinomatosis (PC) had long been regarded as a terminal disease, characterized by a very...
Background: The peritoneum is the preferred site of metastasis from several primary malignancies, an...
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIP...
Abstract Background Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cance...
Complete cytoreductive surgery (CCRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) is the ...
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologi...
Peritoneal Carcinomatosis (PC) is a late stage manifestation of several gastrointestinal malignancie...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. Th...
Background: Diagnosis of peritoneal carcinomatosis (PC) may be missed by preoperative imaging. We ar...
A subset of patients with colorectal cancer (CRC) develops synchronous or metachronous isolated peri...
Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surger...
Approximately 5% of colorectal cancer (CRC) patients will develop peritoneal carcinomatosis (PC) in ...
Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic...
The present study evaluates the accuracy of computed tomographic (CT) scan and positron emission tom...
OBJECTIVE: To review the literature with regard to the incidence and prognostic significance of peri...
Peritoneal carcinomatosis (PC) had long been regarded as a terminal disease, characterized by a very...
Background: The peritoneum is the preferred site of metastasis from several primary malignancies, an...
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIP...
Abstract Background Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cance...
Complete cytoreductive surgery (CCRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) is the ...
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologi...
Peritoneal Carcinomatosis (PC) is a late stage manifestation of several gastrointestinal malignancie...
Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin is associated with poor outcome. Th...